Canada has informed Swiss Pharmaceutical Roche AG to include the warning about potential side-effects of the well known, influenza drug, Tami flu. This advice is close on the heels of reports about the adverse reaction of the drug, sparking erratic behaviors, hallucination and even inducing self harm. Most of these incidents involved children and teens in Japan.
According to a statement released from the department, "Health Canada has requested that the manufacturer ... update the Canadian prescribing information for Tamiflu to include this new information."
Further, Health Canada confirmed the receipt of 84 reports of Canadian patients suffering serious reactions to the drug, nearly ten of the instances reported included fatalities.